A means and method for treating pulmonary fibrosis in animals is described. The compositions include surfactant lipids in a pharmaceutically acceptable carrier. Surfactant lipids have been found to suppress the synergistic effect of bleomycin and SP-A in enhancing proinflammatory cytokine production. Surfactant lipids are also effective in the prevention and treatment of pulmonary fibrosis resulting from exposure to inflammatory agents affecting cytokine production.

 
Web www.patentalert.com

< Piperizinones as modulators of chemokine receptor activity

< Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors

> Methods of using non-human animal Apolipoprotein A-I protein

> Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
~ 00238